Geographic Atrophy Market: Complement Inhibitors and OCT-A Diagnostics Leading the Charge
The Geographic Atrophy Market is experiencing significant and rapid growth, with specific drug and diagnostic segments acting as primary catalysts. The market, valued at approximately USD 7.06 Billion in 2025, is projected to reach USD 35.80 Billion by 2030, driven by the critical roles of these segments in the evolving treatment paradigm . The Complement...
0 Комментарии 0 Поделились 6 Просмотры 0 предпросмотр